Drug Trial Radar · NCT06429722
To Evaluate the Effects of NMRA-335140 on Symptoms of Major Depression in Participants With Bipolar II Disorder.
Last checked: Nov 20, 2026Latest source record: Mar 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
18
Actual
Start
May 13, 2024
Primary completion
Apr 9, 2025
Study completion May 30, 2025
Sponsor
- Lead sponsor
- Neumora Therapeutics, Inc.Industry
- Sponsor type
- Industry
- First posted
- May 28, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a randomized, double-blind, placebo-controlled pilot study aiming to evaluate the effects of NMRA-335140 on symptoms of major depression in adults with Bipolar (BP) II disorder. The study design consists of a Screening Period (up to 28 days), a 6-week Treatment Period (during which participants will receive either NMRA-335140 or placebo), and a 6-week Safety Follow-up Period.
Conditions
- Major Depressive Episode Associated With Bipolar II Disorder
Interventions
NMRA-335140 80 mgDrug
Participants will receive NMRA-335140 at a dose of 80 mg QD, orally.
PlaceboDrug
Placebo will be administered orally
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from Baseline to Week 6 in the Montgomery-Asberg Depression Rating Scale (MADRS) total scoreTime frame: Baseline and up to Week 6
Locations
21 sites in 1 country. Site status is shown where the registry gives one.
Neumora Investigator Site
Phoenix, Arizona
Neumora Investigator Site
Little Rock, Arkansas
Neumora Investigator Site
Garden Grove, California
Neumora Investigator Site
Long Beach, California
Neumora Investigator Site
San Jose, California
Neumora Investigator Site
Torrance, California
Neumora Investigator Site
Gainesville, Florida
Neumora Investigator Site
Lauderhill, Florida
Neumora Investigator Site
Maitland, Florida
Neumora Investigator Site
Miami, Florida
Neumora Investigator Site
Miami Lakes, Florida
Neumora Investigator Site
Marietta, Georgia
Neumora Investigator Site
Savannah, Georgia
Neumora Investigator Site
Watertown, Massachusetts
Neumora Investigator Site
Flowood, Mississippi
Neumora Investigator Site
Marlton, New Jersey
Neumora Investigator Site
Princeton, New Jersey
Neumora Investigator Site
Toms River, New Jersey
Neumora Investigator Site
Brooklyn, New York
Neumora Investigator Site
Houston, Texas
Neumora Investigator Site
Bellevue, Washington
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.